BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review

BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDME225FSA
  • |
  • Pages: 54
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company's Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also developing Renevia facial aesthetics product, a potential treatment for facial lipoatrophy; AST-VAC1 and AST-VAC2 autologous (patient-specific) cancer vaccines; Premvia for tendon and wound-management applications; OpRegen for the treatment of dry form of age-related macular degeneration (AMD); AST-OPC1 for spinal cord injury rehabilitation; HyStem hydrogel products; and mobile health software products. BioTime's products can be used in oncology, neuroscience, orthopedics and blood and vascular diseases. Its products are developed on its pluripotent stem technology. The company has operations in the US, Hong Kong, Israel and Singapore. BioTime is headquartered in California, the US.

BioTime Inc Key Recent Developments

Aug 02,2018: BioTime reports second quarter results and recent corporate accomplishments-2018

Aug 02,2018: BioTime reports second quarter results and recent corporate accomplishments for 2018

Jun 29,2018: BioTime Awarded Grant from the National Institutes of Health

Jun 29,2018: BioTime Awarded Grant From the NIH (National Institutes of Health)

Jun 05,2018: AgeX Therapeutics Appoints John F. Mauldin to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

BioTime Inc - Key Facts 6

BioTime Inc - Key Employees 7

BioTime Inc - Key Employee Biographies 8

BioTime Inc - Major Products and Services 9

BioTime Inc - History 10

BioTime Inc - Company Statement 14

BioTime Inc - Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Joint Venture 16

Section 2 - Company Analysis 17

Company Overview 17

BioTime Inc - Business Description 18

BioTime Inc - SWOT Analysis 19

SWOT Analysis - Overview 19

BioTime Inc - Strengths 19

BioTime Inc - Weaknesses 20

BioTime Inc - Opportunities 21

BioTime Inc - Threats 22

BioTime Inc - Key Competitors 23

Section 3 - Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios - Interim Ratios 29

Financial Ratios - Ratio Charts 30

Section 4 - Company's Lifesciences Financial Deals and Alliances 31

BioTime Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

BioTime Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32

BioTime Inc, Recent Deals Summary 33

Section 5 - Company's Recent Developments 34

Aug 14, 2018: Oncocyte reports second quarter 2018 financial results and positive corporate developments 34

Aug 02, 2018: BioTime reports second quarter results and recent corporate accomplishments-2018 36

Jun 05, 2018: AgeX Therapeutics Appoints John F. Mauldin to Board of Directors 38

May 15, 2018: OncoCyte Reports First Quarter 2018 Financial Results 39

May 10, 2018: BioTime Reports First Quarter Results and Recent Corporate Accomplishments 41

Apr 03, 2018: Leading Molecular Diagnostics Executive Ronnie Andrews Appointed to OncoCyte's Board of Directors 43

Apr 02, 2018: OncoCyte Names Cavan Redmond Chairman of the Board of Directors 44

Apr 02, 2018: OncoCyte Files Patents for 190 Newly Identified Novel Lung Cancer Biomarkers 45

Apr 02, 2018: Oncocyte Reports Fourth Quarter and Full Year 2017 Financial Results 46

Mar 15, 2018: BioTime Reports Fourth Quarter and Fiscal 2017 Results 48

Section 6 - Appendix 50

Methodology 50

Ratio Definitions 50

About GlobalData 54

Contact Us 54

Disclaimer 54

List of Figures

BioTime Inc, Performance Chart (2013 - 2017) 28

BioTime Inc, Ratio Charts 30

BioTime Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

BioTime Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 32

List of Tables

BioTime Inc, Key Facts 6

BioTime Inc, Key Employees 7

BioTime Inc, Key Employee Biographies 8

BioTime Inc, Major Products and Services 9

BioTime Inc, History 10

BioTime Inc, Subsidiaries 15

BioTime Inc, Joint Venture 16

BioTime Inc, Key Competitors 23

BioTime Inc, Ratios based on current share price 24

BioTime Inc, Annual Ratios 25

BioTime Inc, Annual Ratios (Cont...1) 26

BioTime Inc, Annual Ratios (Cont...2) 27

BioTime Inc, Interim Ratios 29

BioTime Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 31

BioTime Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 32

BioTime Inc, Recent Deals Summary 33

Currency Codes 50

Capital Market Ratios 50

Equity Ratios 51

Profitability Ratios 51

Cost Ratios 52

Liquidity Ratios 52

Leverage Ratios 53

Efficiency Ratios 53

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]


Noveome Biotherapeutics Inc

Hospira Inc

Geron Corp

Baxter International Inc

B. Braun Melsungen AG

Alpha Therapeutic Corp

BioTime Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8905
Site License
USD 250 INR 17810
Corporate User License
USD 375 INR 26715



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]